Detection of free radical-induced DNA damage with bromodeoxyuridine/Hoechst flow cytometry: implications for Bloom's syndrome.
The clinical radiosensitizer bromodeoxyuridine (BrdU) was shown to enhance oxygen free radical-mediated growth inhibition. Cells from Bloom's syndrome, a rare autosomal recessive disorder characterized by pre- and post-natal growth deficits, telangiectatic erythema, recurrent respiratory infections and a high incidence of cancer, exhibit in culture a hypersensitivity to BrdU. We analysed disturbed cell kinetics of Bloom's syndrome fibroblasts and permanent B-cell lines with a novel cell kinetic method: BrdU/Hoechst flow cytometry. Fibroblasts show a pattern similar to that of normal cells exposed to a breakdown product of lipid peroxides, whereas B-cells exhibit the cell kinetic disturbance provoked by elevated oxygen concentrations in normal cells. In both cell types the cell kinetic pattern was dependent upon the BrdU concentration in the culture medium. These data suggest an elevated endogenous generation of oxygen free radicals in Bloom's syndrome cells, which may relate to the elevated incidence of malignancies in these patients.
Department of Human Genetics, University of Würzburg, F.R.G.
M
M
Poot
H W
HW
Rüdiger
H
H
Hoehn
D001402:B-Lymphocytes / Q000502:physiology; D006690:Bisbenzimidazole; D001816:Bloom Syndrome / Q000235:genetics*; D001973:Bromodeoxyuridine; D002453:Cell Cycle; D002472:Cell Transformation, Viral; D004247:DNA / Q000032:analysis*; D004249:DNA Damage; D005347:Fibroblasts / Q000502:physiology; D005434:Flow Cytometry; D005609:Free Radicals; D004854:Herpesvirus 4, Human; D006801:Humans; D010100:Oxygen / Q000378:metabolism
D005609:Free Radicals; D004247:DNA; D001973:Bromodeoxyuridine; D006690:Bisbenzimidazole; D010100:Oxygen